Crinetics Pharmaceuticals, Inc. Selling, General and Administrative Expense
Crinetics Pharmaceuticals, Inc. (CRNX) reported Selling, General and Administrative Expense of $191.33 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-02-26
- Crinetics Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2025-06-30 was $49.84M, a 100.67% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2025-03-31 was $35.53M, a 70.57% increase year-over-year.
- Crinetics Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2024-06-30 was $24.84M.
- Crinetics Pharmaceuticals, Inc. selling, general and administrative expense for the quarter ending 2024-03-31 was $20.83M.
- Crinetics Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2025 was $191.33M, a 91.84% increase from fiscal 2024.
- Crinetics Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2024 was $99.74M, a 71.68% increase from fiscal 2023.
- Crinetics Pharmaceuticals, Inc. selling, general and administrative expense for fiscal 2023 was $58.09M.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|
| 2025-12-31 | $191.33M 10-K · filed 2026-02-26 | ||
| 2025-06-30 | $49.84M 10-Q · filed 2025-08-07 | $85.37M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $35.53M 10-Q · filed 2025-05-08 | ||
| 2024-12-31 | $99.74M 10-K · filed 2026-02-26 | ||
| 2024-06-30 | $24.84M 10-Q · filed 2025-08-07 | $45.67M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $20.83M 10-Q · filed 2025-05-08 | ||
| 2023-12-31 | $58.09M 10-K · filed 2026-02-26 |